Cyclin D1 protein in multiple myeloma and plasmacytoma: An immunohistochemical study using fixed, paraffin-embedded tissue sections

Modern Pathology

Volumn 10, Issue 9, 1997, Pages 927-932

  Vasef, Mohammad A ^a   Medeiros, L Jeffrey ^a   Yospur, Lisa S ^b   Sun, Nora C J ^b   McCourty, Althea ^a   Brynes, Russell K ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Bcl 1; Cyclin D1; Multiple myeloma; Plasmacytoma; T(11; 14)(q13; q32)

Indexed keywords

CYCLIN D1; DNA; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; PARAFFIN;

ADULT; AGED; ARTICLE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE MYELOMA; PLASMACYTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; PROTEIN EXPRESSION; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CYCLIN D1; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, PLASMACYTIC; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAFFIN EMBEDDING; PLASMACYTOMA; POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 0030810392     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sawyer JR, Waldron JA, Jagannath S, Barlogie B. Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 1995;82:41-9.
2. Dewald GW, Kyle RA, Hicks GA, Greipp PR. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 1985;66:380-90.
3. Weh HJ, Gutensohn K, Selbach J, Kruse R, Wacker-Backhaus G, Seeger D, et al. Karyotype in multiple myeloma and plasma cell leukemia. Eur J Cancer 1993;29A:1269-73.
4. Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, et al. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders. Primary breakpoints and clinical correlations. Genes Chromosom Cancer 1997;18:84-93.
5. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, et al. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci U S A 1991;88:9638-42.
6. Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell 1991;65:691-9.
7. De Boer CJ, van Krieken JHJM, Kluin-Nelemans HC, Kluin PM, Schuuring E. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 1995;10: 1833-40.
8. Bosch F, Campo E, Jares P, Pittaluga S, Munoz J, Nayach I, et al. Increased expression of PRAD-1/CCND1 gene in hairy cell leukemia. Br J Haematol 1995;91:1025-30.
9. Kobayashi H, Kitano K, Saito H, Aoki K, Narita A, Terada N, et al. Overexpression of the PRAD1 oncogene in a patient with prolymphocytic leukemia with t(11;14)(q13;32). Cancer Genet Cytogenet 1995;84:69-72.
10. Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris MA, Villamor N, et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994;84:2726-32.
11. Kobayashi H, Saito H, Kitano K, Kiyosawa K, Gaun S, Aoki K, et al. Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32). Acta Haematol 1995;94:199-203.
12. Zukerberg LR, Yang W, Arnold A, Harris NL. Cyclin D1 expression in non-Hodgkin's lymphoma. Detection by immunohistochemistry. Am J Clin Pathol 1995;103:756-60.
13. Yang W, Zukerberg LR, Motokura T, Arnold A, Harris, NL. Cyclin D1 (bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994;145:86-96.
14. Banno S, Yoshikawa K, Nakamura S, Yamamoto K, Seito T, Nitta M, et al. Monoclonal antibody against PRAD1/ cyclin D1 stains nuclei of tumor cells with translocation or amplification at bcl-1 locus. Jpn J Cancer Res 1994;85: 918-26.
15. Kuroda H, Komatsu H, Nakamura S, Niitsu Y, Takahashi T, Ueda R, et al. The positive nuclear staining observed with monoclonal antibody against PRAD1/cyclin D1 correlates with mRNA expression in mantle cell lymphoma. Jpn J Cancer Res 1995;86:890-8.
16. De Boer CJ, Schuuring E, Dreef E, Peters G, Bartek J, Kluin PM, et al. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 1995;86:2715-23.
17. Brynes RK, McCourty A, Tamayo R, Jenkins K, Battifora H. Demonstration of cyclin D1 (bcl-1) in mantle cell lymphoma. Enhanced staining using heat and ultrasound epitope retrieval. Appl Immunohistochem 1997;5:45-8.
18. Vasef MA, Medeiros LJ, Koo C, McCourty A, Brynes RK. Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow. Am J Clin Pathol 1997;108: 302-7.
19. Rimokh R, Berger K, Delsol G, Digonnet I, Rouault JP, Tigaud JD, et al. Detection of the chromosomal translocation t(11; 14) by polymerase chain reaction in mantle cell lymphomas. Blood 1994;83:1871-5.
20. Liu J, Johnson RM, Traweek, ST. Rearrangement of the bcl-2 gene in follicular lymphoma. Diagn Mol Pathol 1993;2:241-7.
21. Bartl R, Frisch B, Fateh-Moghadam A, Kettner G, Jaeger K, Sommerfeld W. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol 1987;87:342-55.
22. Brunning R, McKenna RW. Tumors of the bone marrow. In: Rosai J, Sabin LH, editors. Atlas of tumor pathology. Third series, Fascicle 9. Washington, D.C.: Armed Forces Institute of Pathology; 1994. p. 323-67.
23. McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 1995; 11:885-91.
24. Bartl R, Frisch B, Burkhardt R, Fateh-Moghadam A, Mahl G, Gierster P, et al. Bone marrow histology in myeloma. Its importance in diagnosis, prognosis, classification, and staging. Br J Haematol 1982;51:361-75.
25. Vercelli D, Di Guglielmo R, Guidi G, Scolari L, Buricchi L, Cozzolino F. Bone marrow percentage of plasma cells in the staging of monoclonal gammopathies. Nouv Rev Fr Hematol 1980;22:139-45.